Evidence map›Paper›PMID 37609156›Full record

ArticlebioRxiv : the preprint server for biology2023

Using deep long-read RNAseq in Alzheimer's disease brain to assess medical relevance of RNA isoform diversity.

Bernardo Aguzzoli Heberle, J Anthony Brandon, Madeline L Page, Kayla A Nations, Ketsile I Dikobe, Brendan J White, Lacey A Gordon, Grant A Fox, Mark E Wadsworth, Patricia H Doyle and 13 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 14 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 2 countries.

Bernardo Aguzzoli HeberleSanders-Brown Center on Aging, University of Kentucky, Lexington, KY.ORCID 0000-0002-6177-9316
J Anthony BrandonSanders-Brown Center on Aging, University of Kentucky, Lexington, KY.
Madeline L PageSanders-Brown Center on Aging, University of Kentucky, Lexington, KY.
Kayla A NationsSanders-Brown Center on Aging, University of Kentucky, Lexington, KY.
Ketsile I DikobeSanders-Brown Center on Aging, University of Kentucky, Lexington, KY.
Brendan J WhiteSanders-Brown Center on Aging, University of Kentucky, Lexington, KY.
Lacey A GordonSanders-Brown Center on Aging, University of Kentucky, Lexington, KY.
Grant A FoxSanders-Brown Center on Aging, University of Kentucky, Lexington, KY.
Mark E WadsworthSanders-Brown Center on Aging, University of Kentucky, Lexington, KY.
Patricia H DoyleSanders-Brown Center on Aging, University of Kentucky, Lexington, KY.
Brittney A WilliamsDepartment of Pharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, Lexington, KY.
Edward J FoxDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.
Anantharaman ShantaramanDepartment of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
Mina RytenGenetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London, UK.
Sara GoodwinCold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States.
Elena GhibanCold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States.
Robert WappelCold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States.
Senem Mavruk-EskipehlivanCold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States.
Justin B MillerSanders-Brown Center on Aging, University of Kentucky, Lexington, KY.
Nicholas T SeyfriedDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.ORCID 0000-0002-4507-624X
Peter T NelsonSanders-Brown Center on Aging, University of Kentucky, Lexington, KY.
John D FryerDepartment of Neuroscience, Mayo Clinic, Scottsdale, Arizona.
Mark T W EbbertSanders-Brown Center on Aging, University of Kentucky, Lexington, KY.ORCID 0000-0001-9158-4440
University of Kentucky · USCold Spring Harbor Laboratory · USEmory University · USGreat Ormond Street Hospital · GBMayo Clinic in Arizona · US

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
University of Kentucky Alzheimer's Disease Research CenterP30AG072946 · NIA · UNIVERSITY OF KENTUCKY · PI LINDA J VAN ELDIK · 2021 to 2026
$23.5M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Using long-range technologies as a multi-omic approach to understand Alzheimer’s disease in brain tissueR01AG068331 · NIA · UNIVERSITY OF KENTUCKY · PI EBBERT, MARK T W · 2020 to 2024
$3.0M
Understanding how structural mutations and individual RNA isoformsare involved in human health and diseaseR35GM138636 · NIGMS · UNIVERSITY OF KENTUCKY · PI Mark T W Ebbert · 2020 to 2026
$2.9M
Training in Translational Research in Alzheimer's and Related Dementias (TRIAD)T32AG078110 · NIA · UNIVERSITY OF KENTUCKY · PI Michael Paul Murphy, LINDA J VAN ELDIK · 2022 to 2026
$2.3M
Functional Genomic Study of Aging and Aging InterventionsZ01AG000365 · NIA · NATIONAL INSTITUTE ON AGING · PI ZOU, SIGE · 2005 to 2008
$1.1M
The Development and Optimization of Long-Read Sequencing Applications to Cancer Genomics in a Core SettingR50CA243890 · NCI · COLD SPRING HARBOR LABORATORY · PI GOODWIN, SARA · 2019 to 2025
$920k
Intramural NIH HHS Z01 AG000365NCI NIH HHS R50 CA243890NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG072946NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG068331NIA NIH HHS T32 AG078110NIGMS NIH HHS R35 GM138636
6 · The paper itself

Abstract

Due to alternative splicing, human protein-coding genes average over eight RNA isoforms, resulting in nearly four distinct protein coding sequences per gene. Long-read RNAseq (IsoSeq) enables more accurate quantification of isoforms, shedding light on their specific roles. To assess the medical relevance of measuring RNA isoform expression, we sequenced 12 aged human frontal cortices (6 Alzheimer's disease cases and 6 controls; 50% female) using one Oxford Nanopore PromethION flow cell per sample. Our study uncovered 53 new high-confidence RNA isoforms in medically relevant genes, including several where the new isoform was one of the most highly expressed for that gene. Specific examples include

Indexed as

Alzheimer’s diseaseHuman brainLong readsMedical relevanceNanopore sequencingRNA isoforms

Identifiers

PMID37609156
PMCPMC10441303
OpenAlexW4385622495

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.